TegoScience Inc. (KOSDAQ:191420)
South Korea flag South Korea · Delayed Price · Currency is KRW
7,530.00
+390.00 (5.46%)
At close: Aug 11, 2026

TegoScience Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,8275,9416,7597,7727,6788,300
Revenue Growth
-14.28%-12.11%-13.04%1.23%-7.49%-5.57%
Gross Profit
3,8724,0054,7615,2775,6006,364
Operating Income
-5,403-4,424-2,606-1,185229.63-98.01
Net Income
-8,359-7,0123,350-2,323264.51139.26
Earnings Per Share
-1044.73-876.00418.00-290.0833.0017.00
EPS Growth
----94.12%-92.51%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
48,09951,44127,33920,91522,30821,311
Total Debt
16,58416,1561,7571,5451,1511,045
Net Cash (Debt)
31,51535,28425,58219,37021,15720,267
Net Cash Growth
25.54%37.93%32.07%-8.45%4.39%-5.05%
Net Cash Per Share
3938.054406.943195.102419.292641.882519.70

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5,711-3,067-1,160-794.611,040457.25
Capital Expenditures
-52.87-49.3-36.6-36.13-15.47-16.19
Free Cash Flow
-5,763-3,116-1,196-830.741,025441.05
Free Cash Flow Growth
----132.37%-63.68%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
66.45%67.41%70.44%67.89%72.93%76.68%
Operating Margin
-92.73%-74.48%-38.56%-15.24%2.99%-1.18%
Pretax Margin
-163.66%-136.47%42.00%-32.97%2.63%0.80%
Profit Margin
-143.46%-118.04%49.56%-29.88%3.45%1.68%
FCF Margin
-98.91%-52.45%-17.70%-10.69%13.35%5.31%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--29.85-369.281249.73
P/FCF Ratio
----95.31394.58
PS Ratio
10.3521.9714.8015.1012.7220.97